Building an Effective Data Safety Monitoring Board
Building an Effective Data Safety Monitoring Board (DSMB): A Sponsor’s Quick-Start Guide

In July 2002, the US Women’s Health Initiative stopped its estrogen plus progestin trial about three years early. The trial had enrolled 16,608 women. Its data safety monitoring board had found that health risks exceeded the benefits, and its recommendation was unanimous.  That call protected thousands of women. It worked because the board, its stopping […]

Patient Recruitment Strategies
How Patient Recruitment Strategies Impact Clinical Trial Timelines Patient Recruitment Strategies Impact Clinical Trial Timelines

Most clinical trials do not slip because the science fails. They slip because patients do not enrol fast enough.  According to National Library of Medicine, recruitment can take up to 30% of the drug development timeline, and delays of one to six months are common.   For pharma teams, this makes clinical trial recruitment strategies one […]

The Role of Biospecimens in Advancing Emerging Oncology Modalities
The Role of Biospecimens in Advancing Emerging Oncology Modalities

Introduction  The oncology landscape is undergoing a remarkable transformation. Advances in precision medicine, immunotherapy, cell and gene therapies, antibody-drug conjugates (ADCs), and targeted therapies are redefining how cancer is diagnosed, treated, and monitored. These emerging oncology modalities are enabling more personalized treatment approaches, improving patient outcomes, and accelerating the development of innovative therapeutics.  Behind these […]